Etonogestrel structure
|
Common Name | Etonogestrel | ||
|---|---|---|---|---|
| CAS Number | 54048-10-1 | Molecular Weight | 324.457 | |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 473.1±45.0 °C at 760 mmHg | |
| Molecular Formula | C22H28O2 | Melting Point | 182-184ºC | |
| MSDS | Chinese USA | Flash Point | 201.1±21.3 °C | |
| Symbol |
GHS08 |
Signal Word | Danger | |
| Name | etonogestrel |
|---|---|
| Synonym | More Synonyms |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 473.1±45.0 °C at 760 mmHg |
| Melting Point | 182-184ºC |
| Molecular Formula | C22H28O2 |
| Molecular Weight | 324.457 |
| Flash Point | 201.1±21.3 °C |
| Exact Mass | 324.208923 |
| PSA | 37.30000 |
| LogP | 4.22 |
| Vapour Pressure | 0.0±2.7 mmHg at 25°C |
| Index of Refraction | 1.575 |
| Storage condition | -20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H351-H360 |
| Precautionary Statements | P201-P280-P308 + P313 |
| Hazard Codes | Xn |
| Risk Phrases | 60-40 |
| RIDADR | NONH for all modes of transport |
| RTECS | JF8290000 |
|
Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs.
Contraception 90(2) , 123-9, (2014) The potential effect of hormonal contraception on HIV-1 acquisition and transmission represents an important public health issue. Several observational studies have suggested an association between th... |
|
|
Newer non-oral hormonal contraception.
BMJ 346 , f341, (2013)
|
|
|
The combined etonogestrel/ethinyl estradiol contraceptive vaginal ring.
Expert Opin. Pharmacother. 8(11) , 1769-77, (2007) Many factors influence the effectiveness of contraceptive methods. Oral contraceptives are the second most popular contraceptive method after female sterilization in the US. A total of 25% of women do... |
| EINECS 258-936-2 |
| 3-Ketodesogestrel,3-Oxodesogestrel,Org-3236,Implanon |
| Etonoestrel |
| 3-Keto-desogestrel 3-Oxo-desogestrel |
| (17a)-13-Ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-one |
| 3-Oxodesogestrel |
| 3-Keto-Org 2969 |
| 18,19-Dinor-17α-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-11-methylene- |
| 3-keto-desogestrel |
| (8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one |
| 13-Ethyl-17-hydroxy-11-methylene-18,19-dinor-17α-pregn-4-en-20-yn-3-one |
| 3-Ketodesogestrel |
| Etonogestrel |
| Nexplanon |
| Desogestrel Related Compound C (25 mg) (3-Keto-desogestrel) |
| (8S,9S,10R,13S,14S,17R)-17-Ethinyl-13-ethyl-17-hydroxy-11-methyliden-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-on |
| UNII-304GTH6RNH |
| MFCD00867863 |
| Implanon |
| [3H]-3-keto-Desogestrel |
| org3236 |
| (8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one (non-preferred name) |
| 17-Ethinyl-17b-hydroxy-18-methyl-11-methylene-4-estren-3-one |
| (8S,9S,10R,13S,14S,17R)-13-Ethyl-17-ethynyl-17-hydroxy-11-methylene-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one |